Higher Dose Buprenorphine in Treatment Retention: Fentanyl Considerations
Higher Dose Buprenorphine in Treatment Retention: Fentanyl Considerations

The Addiction Files

This week we review the journal article "Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl." how do we manage patients on high dose synthetic opioids. Hosted by Paula Cook, MD and Darlene Pe...

Thought-provokingInformativeEmpoweringTransformativeHopeful

33:25•15 Nov 2023

RSS Feed

About this podcast

The Addiction Files

Darlene Petersen, MD and Paula Cook, MD

Darlene Petersen, MD and Paula Cook, MD are board certified addiction medicine and family medicine physicians providing evidence based education, clinical pearls and resources to physicians, residents and students while striving to destigmatize the treatment of addiction in our medical culture and save lives. Tune in to learn about the latest treatments for all things addiction. Join us as we conduct expert interviews, review clinical pearls and best practices and discuss the latest updates in addiction medicine. No explicit language but this podcast discusses the abuse and treatment of legal and illegal drugs and may not be appropriate for all listeners.

Understanding AddictionDependencyNutritionTreatmentsSobriety Toolkit

Episodes: 103

View Podcast Visit External Site

Do you want to link to this podcast?
Get the buttons here!

Buprenorphine and Fentanyl: Rethinking Opioid Treatment Strategies

Episode Overview

The study examines the trend of higher doses for fentanyl and the initiation of buprenorphine in treating opioid use disorder.
Considerations are discussed regarding the potential need for higher doses of buprenorphine in the context of fentanyl's unique properties and rapid physiological dependence.
The limitations and implications of the study are explored, shedding light on the complexities of treating opioid use disorder in the current landscape.
Key takeaways include insights into personalized treatment plans, retention strategies, and the challenges in addiction medicine, prompting critical conversations in the field.
The episode offers valuable considerations for healthcare professionals, patients, and individuals interested in the latest developments in addiction medicine.

“Even without best treatment, we have over half of the people leaving treatment in six months. Buprenorphine and methadone aren't equally as good as each other. And that's pretty much what we've got. We're looking at a really serious, chronically relapsing, deadly condition, opioid use disorder.”

When it comes to treating opioid use disorder, the game has changed with the rise of fentanyl. In this episode of 'The Addiction Files', Dr. Darlene Petersen and Dr. Paula Cook tackle a pressing issue: how do higher doses of buprenorphine affect treatment retention for patients grappling with fentanyl addiction?

Drawing from the study 'Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl', our hosts dive into the nuances of managing high-dose synthetic opioids. This isn’t just a clinical discussion; it’s a vital conversation about adapting treatment plans to meet the evolving challenges of opioid addiction. Whether you're a healthcare professional, a patient, or someone interested in the latest in addiction medicine, this episode offers a wealth of insights.

From the need for personalized treatment plans to the study's limitations and broader implications, Drs. Petersen and Cook guide you through the complexities with clarity and compassion. Tune in for an enlightening discussion that could reshape your understanding of opioid treatment strategies.

PreviousThe Grief of Overdose Death

NextInhalant Misuse